<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOph</journal-id><journal-title-group><journal-title>Open Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="epub">2165-7408</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojoph.2022.123022</article-id><article-id pub-id-type="publisher-id">OJOph-119458</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Incidence of Primary Open-Angle Glaucoma at the Flamboyants Communal Medical Center of Conakry, Guinea
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Pierre</surname><given-names>Louis Lama</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Aly</surname><given-names>Sylla</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sidikiba</surname><given-names>Camara</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Céougna</surname><given-names>Sagno</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Oumar</surname><given-names>Raphiou Diallo</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ibrahima</surname><given-names>Sory Souaré</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff4"><addr-line>Department of Neurosurgery, Sino Guinean Friendship Hospital, Conakry, Guinea</addr-line></aff><aff id="aff3"><addr-line>FSTS, Gamal Abdel Nasser University of Conakry, Conakry, Guinea</addr-line></aff><aff id="aff2"><addr-line>Department of Ophthalmology, Regional Hospital of N’Zerekore, Zerekore, Guinea</addr-line></aff><aff id="aff1"><addr-line>National Noncommunicable Diseases Programme, Conakry, Guinea</addr-line></aff><pub-date pub-type="epub"><day>18</day><month>08</month><year>2022</year></pub-date><volume>12</volume><issue>03</issue><fpage>233</fpage><lpage>241</lpage><history><date date-type="received"><day>8,</day>	<month>April</month>	<year>2022</year></date><date date-type="rev-recd"><day>23,</day>	<month>August</month>	<year>2022</year>	</date><date date-type="accepted"><day>26,</day>	<month>August</month>	<year>2022</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Background: Primary Open-Angle Glaucoma (POAG) is a chronic, progressive optic neuropathy of multifactorial origin defined by alterations in the visual field, progressive loss of optic nerve fibers and ganglion cells, and an open iridocorneal angle in gonioscopy. It is the world’s leading cause of irreversible blindness. There is no epidemiological study in Guinea that allows us to locate the real level of the problem. The objective of this study is to determine the hospital incidence of POAG at the Centre M&#233;dical Communal (CMC) in the Flamboyants. 
  Patients and Method: This was a descriptive cross-sectional study with a prospective collection for one year, from April 1, 2020 to March 31, 2021, in patients aged at least 40 years, received in consultation at the CMC in the Flamboyants. The diagnostic criterion for a new case of glaucoma was the presence in a patient of the following two signs: (excavation of the optical disc C/D ≥ 0.5 and alteration of the visual field) with an open angle at least stage 4 of the Shaffer and Etienne classification associated or not with ocular hypertonia and having never received anti glaucoma treatment. We described variables related to sociodemographic characteristics, visual acuity, intraocular pressures, papillary excavations, and visual field surveys. Informed consent from patients was sought and obtained. The confidentiality of the files was guaranteed. 
  Results: 68 new cases of POAG were diagnosed out of 3220 consultations, an incidence rate of 2.11%. The average age was 58.2 years (10.64 with a male predominance of 63.23%. A family history of glaucoma was present in 11.36% of cases. Visual acuity was poor &lt; 1/10 in 79 eyes/136, average between 1/10 and 3/10 in 11 eyes/136, and good ≥ 3/10 in 46 eyes/136. The mean intraocular pressure (IOP) was 26.5 mm Hg in the right eye and 25.9 mm Hg in the left eye with extremes of 18 and 38 mm Hg. The cup/disk ratio was above 0.5 in 97.1% at OD and 95.58% at OG. The visual field was impaired in all patients. 
  Conclusion: This study has shown us that POAG in our environment is relatively common, early onset, and rapidly evolving. The implementation of a rapid and reliable screening strategy by the Eye Health Program will make it possible to manage glaucoma from the earliest stages.
 
</p></abstract><kwd-group><kwd>Primary Glaucoma</kwd><kwd> Open-Angle</kwd><kwd> Incidence</kwd><kwd> Conakry</kwd><kwd> Guinea</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Background</title><p>Primary Open-Angle Glaucoma (POAG) is a chronic, progressive, multifactorial optic neuropathy [<xref ref-type="bibr" rid="scirp.119458-ref1">1</xref>]. It is characterized by an acquired degeneration on optical fibers. Such a loss develops while the iridocorneal angle is wide, with abnormalities characteristic of the visual field and generally high intraocular pressure. This neuropathy is manifested by excavation and atrophy of the head of the optic nerve [<xref ref-type="bibr" rid="scirp.119458-ref1">1</xref>]. It is the 2<sup>nd</sup> leading cause of blindness worldwide after cataracts and the leading cause of irreversible blindness whose main risk factor is ocular hypertonia [<xref ref-type="bibr" rid="scirp.119458-ref2">2</xref>]. The POAG is the most common glaucoma since it represents 50 to 70% of all glaucoma depending on the region and diagnostic criteria and is believed to be the cause of 6.4 million cases of blindness worldwide [<xref ref-type="bibr" rid="scirp.119458-ref2">2</xref>]. The prevalence of POAG varies by race. It is relatively low in a European-type population of the order of 1% of people over 40 years of age, and is higher in blacks where glaucoma is earlier, more severe, and also more difficult to treat [<xref ref-type="bibr" rid="scirp.119458-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref4">4</xref>]. In Africa, some studies have been carried out on the epidemiology of POAG, including the one carried out in Benin by Yehouessi L et al. [<xref ref-type="bibr" rid="scirp.119458-ref5">5</xref>] in 2009, and in Mali by Sidib&#233; M et al. [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] in 2017, which found a prevalence of 5.5% and 5.68% respectively. In Cameroon, studies conducted by Ellong A et al. [<xref ref-type="bibr" rid="scirp.119458-ref7">7</xref>] and Moukouri E and Moli M C [<xref ref-type="bibr" rid="scirp.119458-ref8">8</xref>] found a prevalence of POAG of 4.3% and 1.67% respectively. There are very little data on the incidence of blindness due to glaucoma. The study by Leske M C et al. [<xref ref-type="bibr" rid="scirp.119458-ref9">9</xref>] of the incidence of open-angle glaucoma in Black populations in Barbados found variable incidence rates ranging from 1.2% among those aged 40 to 49 to 4.2% among those aged 70 and older, tending to be higher in males than females (2.7% versus 1.9%). The increasing number of new cases of glaucoma detected in recent years at the communal medical center motivated the present study. The purpose of this work was to determine the hospital incidence of POAG at the communal medical center (CMC) the Flamboyants and to describe sociodemographic and clinical characteristics.</p></sec><sec id="s2"><title>2. Patients and Method</title><p>This was a prospective study over a period of one year, from April 1, 2020 to March 31, 2021, carried out at the communal medical center (CMC) Les Flamboyants in the commune of Ratoma in Conakry. We included in this study all patients aged at least 40 years, whose discovery of POAG was made for the first time. We conducted an interview specifying sociodemographic characteristics, and personal and family history before determining visual acuity in all patients using the Monnoyer and Snellen optotype scale, placed at 5 m. The patients were installed with the slit lamp for the examination of the anterior segment, the measurement of the IOP of each eye at the Goldman’s applanation tonometer after instillation of fluorescein, and oxybuprocaine (Novesine&#174;) and the fundus. Pachymetry was not performed due to a lack of apparatus. Gonioscopy and examination of the optical disc were performed with Goldmann’s three-mirror glass. We used Shaffer and Etienne’s classification to assess the degree of openness of the iridocorneal angle (see <xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Stages 4 and 5 were retained as the open angles. To measure the vertical C/D ratio, we used Goldmann’s three-mirror glass to identify the edge of the papilla, the edge of the excavation, and the neuroretinal ring after tropicamide pupillary dilation. We appreciated the thickness of the neuroretinal ring if it obeyed the Lower &gt; Upper &gt; Nasal rule &gt; Temporal (the ISNT rule). Other abnormalities of the posterior pole were noted. Visual field readings were recorded by the Humphrey Monitor. The diagnostic criterion for a new case of glaucoma was the presence in a patient of the following two signs: (excavation of the optical disc C/D ≥ 0.5 and alteration of the visual field) with an open angle at least stage 4 of the Shaffer and Etienne classification associated or not with ocular hypertonia and having never received anti glaucoma treatment. We excluded all patients under 40 years of age and patients who had previously received anti-glaucoma therapy. The sample was large, including all patients meeting the inclusion criteria and seen during our study period. We described the variables by sociodemographic characteristics, visual acuity at reception, intraocular pressures, papillae examination and visual field readings. Informed consent from patients was sought and obtained. The confidentiality of the files was guaranteed. The data entry was done on EPI-Info version 7 and the analysis using the Stata software. The tables were made on Excel 2010. Pearson’s Chi<sup>2</sup> test or Fisher’s test was used for the comparison of proportions.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Classification of Shaffer and Etienne according to the degree of opening of the iridocorneal angle</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Stage 1</th><th align="center" valign="middle" >Closed angle</th><th align="center" valign="middle" >0˚</th><th align="center" valign="middle" >No visible structure</th></tr></thead><tr><td align="center" valign="middle" >Stage 2</td><td align="center" valign="middle" >Probable closure</td><td align="center" valign="middle" >0˚ - 10˚</td><td align="center" valign="middle" >Visible Schwalbe ring</td></tr><tr><td align="center" valign="middle" >Stage 3</td><td align="center" valign="middle" >Possible closure</td><td align="center" valign="middle" >10˚ - 20˚</td><td align="center" valign="middle" >Scleral spur not visible</td></tr><tr><td align="center" valign="middle" >Stage 4</td><td align="center" valign="middle" >Unable to close</td><td align="center" valign="middle" >20˚ - 35˚</td><td align="center" valign="middle" >Clearly visible spur</td></tr><tr><td align="center" valign="middle" >Stage 5</td><td align="center" valign="middle" >Open</td><td align="center" valign="middle" >35˚ - 45˚</td><td align="center" valign="middle" >All structures are clearly visible up to the ciliary band</td></tr></tbody></table></table-wrap></sec><sec id="s3"><title>3. Results</title><p>Among the 3220 patients aged 40 and over who came to the CMC the Flamboyants during our study period, 68 new cases of POAG were diagnosed, an incidence rate of 2.11%.The majority of patients were male (63.24%) with a sex ratio of 1.71 (<xref ref-type="fig" rid="fig1">Figure 1</xref>). The average age was 58.2 years (10.64 with extremes ranging from 40 to 86 years. The 50 - 69 age groups were the most represented (<xref ref-type="table" rid="table2">Table 2</xref>). A family history of glaucoma was found in 11.36% of patients (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Visual acuity during screening was poor &lt; 1/10 in 39 right eyes (OD) and 40 left eyes (OG), average between 1/10 and 3/10 in 5 eyes (OD) and 6 eyes (OG) and good ≥ 3/10 in 24 OD eyes and 22 OG eyes (<xref ref-type="table" rid="table3">Table 3</xref>). The mean intraocular pressure (IOP) was 26.5 mm Hg in the right eye and 25.9 mm Hg in the left eye with extremes of 18 and 38 mm Hg (<xref ref-type="table" rid="table4">Table 4</xref>). The cup/disk ratio was above 0.5 in 97.1% at OD and 95.58% at OG (<xref ref-type="table" rid="table5">Table 5</xref>). The visual field was impaired in all patients (<xref ref-type="table" rid="table6">Table 6</xref>). All patients diagnosed with POAG, received drug treatment</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Distribution of patients by age group</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Age range (year)</th><th align="center" valign="middle" >Effectif</th><th align="center" valign="middle" >Pourcentage (%)</th></tr></thead><tr><td align="center" valign="middle" >40 - 49</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >20.6</td></tr><tr><td align="center" valign="middle" >50 - 59</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >30.9</td></tr><tr><td align="center" valign="middle" >60 - 69</td><td align="center" valign="middle" >21</td><td align="center" valign="middle" >30.9</td></tr><tr><td align="center" valign="middle" >70 - 79</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >13.2</td></tr><tr><td align="center" valign="middle" >80 - 89</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.4</td></tr><tr><td align="center" valign="middle" >In all</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Distribution of the eyes according to visual acuity (VA) at reception</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >VA</th><th align="center" valign="middle"  colspan="2"  >Right Eye (RE)</th><th align="center" valign="middle"  colspan="2"  >Left Eye (LE)</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >&lt;1/10</td><td align="center" valign="middle" >39</td><td align="center" valign="middle" >57.35</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >58.80</td></tr><tr><td align="center" valign="middle" >1/10 &lt; AV &lt; 3/10</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" >7.35</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >8.80</td></tr><tr><td align="center" valign="middle" >≥3/10</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >35.30</td><td align="center" valign="middle" >22</td><td align="center" valign="middle" >32.40</td></tr><tr><td align="center" valign="middle" >In all</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100</td></tr></tbody></table></table-wrap><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Distribution of eyes by intraocular pressure (IOP) at reception</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >IOP</th><th align="center" valign="middle"  colspan="2"  >Right Eye (RE)</th><th align="center" valign="middle"  colspan="2"  >Left Eye (LE)</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >≤21</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >23.53</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >20.59</td></tr><tr><td align="center" valign="middle" >≥22</td><td align="center" valign="middle" >52</td><td align="center" valign="middle" >76.47</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >79.41</td></tr><tr><td align="center" valign="middle" >In all</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100.00</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100.00</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Distribution of eyes by degree of papillae excavation during screening</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Degree of excavation of the papillae (C/D)</th><th align="center" valign="middle"  colspan="2"  >Right Eye (RE)</th><th align="center" valign="middle"  colspan="2"  >Left Eye (LE)</th></tr></thead><tr><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td><td align="center" valign="middle" >Number</td><td align="center" valign="middle" >%</td></tr><tr><td align="center" valign="middle" >&lt;0.5</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.9</td><td align="center" valign="middle" >3</td><td align="center" valign="middle" >4.4</td></tr><tr><td align="center" valign="middle" >0.5 ≤ C/D &lt; 0.8</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >50.0</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >41.2</td></tr><tr><td align="center" valign="middle" >≥0.8</td><td align="center" valign="middle" >32</td><td align="center" valign="middle" >47.1</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >54.4</td></tr><tr><td align="center" valign="middle" >In all</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100.0</td><td align="center" valign="middle" >68</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><table-wrap id="table6" ><label><xref ref-type="table" rid="table6">Table 6</xref></label><caption><title> Visual field results of the 136 eyes (68 patients)</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Number</th><th align="center" valign="middle" >Percentage (%)</th></tr></thead><tr><td align="center" valign="middle" >Arciform scotoma</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >13.2</td></tr><tr><td align="center" valign="middle" >Deficit in sectors or nasal march</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >19.9</td></tr><tr><td align="center" valign="middle" >Central or temporal island</td><td align="center" valign="middle" >54</td><td align="center" valign="middle" >39.7</td></tr><tr><td align="center" valign="middle" >Field of vision impossible to achieve</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >27.2</td></tr><tr><td align="center" valign="middle" >In all</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" >100.0</td></tr></tbody></table></table-wrap><p>based on prostaglandin analogue (Travoprost) and an interview to explain their disease and the need for lifelong treatment. Surgery (deep sclerosing) was proposed and refused by all cases. At the end of the study we lost sight of more than half of the patients.</p></sec><sec id="s4"><title>4. Discussion</title><p>Among the 3220 consultants ageds 40 and over, 68 new cases of POAG were diagnosed, an incidence rate of 2.11%. This was essentially a hospitable population and therefore the results cannot be extrapolated to the entire Guinean population. However, the geographical location of the CMC the Flamboyants, which covers one of the major municipalities of the capital, gives our sample a representative hospital character. The organization of a survey at the level of all ophthalmology departments in the country could determine the national hospital incidence rate. Our rate is comparable to that found by Leske M C et al. [<xref ref-type="bibr" rid="scirp.119458-ref9">9</xref>] in melanoderms in Barbados, which report incidence rates from 1.2% in those aged 40 to 49 to 4.2% in those aged 70 and older. On the other hand, our incidence rate is higher than those reported by Leske M C et al. [<xref ref-type="bibr" rid="scirp.119458-ref10">10</xref>] in Barbados Eye Study including 3222 subjects with a nine-year follow-up who estimated the incidence of POAG at 4.4%, or 0.49% per year who have in addition to papilla examination and automated visual field readings, had taken photographs of the papillae. For Latinos, the incidence found in the Los Angeles Latino Eye Study of Jiang X et al. [<xref ref-type="bibr" rid="scirp.119458-ref11">11</xref>] was equal to 2.3% for a 4-year follow-up, which corresponds to an incidence of 0.5% per year. The number of new cases in our study could be higher if cases of ocular hypertonia with media disorder could have benefited from fundus biomicroscopy and visual field readings. Our results therefore only partially reflect the importance of POAG at the CMC the Flamboyants where there are almost no patients who come to the systematic glaucoma screening consultation as is the case in developed countries. With regard to sociodemographic characteristics, most epidemiological studies on POAG confirm the increase in the incidence of glaucoma with age [<xref ref-type="bibr" rid="scirp.119458-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref9">9</xref>]. Quigley H A and Vitale S [<xref ref-type="bibr" rid="scirp.119458-ref12">12</xref>] proposed an incidence of primary open-angle glaucoma for blacks from 263 per 100,000 at age 55 to 541 per 100,000 at age 75. Our study confirms this data, in fact, it increases in our series from 20.6% to 30.9% for the respective age groups from 40 to 49 years, 50 to 59 years and 60 to 69 years with an average age of 58.2 years. Data from the literature are contradictory on the frequency of glaucoma by sex. Some studies have found a higher frequency of male sex [<xref ref-type="bibr" rid="scirp.119458-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref15">15</xref>] as was our case (63.24% with a sex ratio of 1.66) and other publications have found an increase in the prevalence of CAPG for the female sex [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref17">17</xref>]. The meta-analysis published by Rudnicka et al. [<xref ref-type="bibr" rid="scirp.119458-ref18">18</xref>] shows that the prevalence of POAG is higher for males (OR: 1.37; 95% CI: 1.22 - 1.53). According to Hulsman C A et al. [<xref ref-type="bibr" rid="scirp.119458-ref19">19</xref>], the existence of protective hormonal factors in women, the involvement of different environmental factors between the two sexes and the role of cardiovascular risk factors would explain this difference. Family history of glaucoma was found in 8 patients, or 11.76% and 4 patients (5.88%) were nearsighted. The majority of patients (82.36%) had no known family history of glaucoma or a personal history of myopia. However, a number of patients had reported a notion of blindness in the family without specifying the cause. Our difficulty in finding a family history of glaucoma can be explained by the population’s lack of knowledge of glaucomatous disease. The assessment of visual acuity found blindness in 39 right eyes, or 57.35%, and 40 left eyes, or 58.82%. This high frequency of blindness shows the severity of this disease. The blindness found in more than half of the patients’ eyes during screening can be explained by the fact that glaucoma occurred early, asymptomatic at the onset stage and rapidly evolving in melanoderma. This late screening trait has been reported by most African authors [<xref ref-type="bibr" rid="scirp.119458-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref17">17</xref>]. The delay in diagnosis could be related to the asymptomatic nature of the disease in its early stage and its insidious course where the decrease in vision occurs only at the ultimate stage. Added to this is the lack of access to eye care in our country. It is established in the literature that melanoderma patients have a higher incidence of POAG and a higher rate of blindness compared to Caucasian patients [<xref ref-type="bibr" rid="scirp.119458-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref15">15</xref>]. Ocular hypertonia (IOP &gt; 21 mm Hg) was found in 76.47% of the right eyes and 79.42% of the left eyes. Normotonia (IOP between 10 and 21 mm Hg) was present in 23.53% of the right eyes and 20.58% of the left eyes. Ocular hypertonia predominated slightly in the left eye with average IOP of 25.9 mmHg in the right eye and 26.5 mmHg in the left eye. More than 3/4 of the patients had high-pressure glaucoma joining the Sidib&#233; M et al. studies in Mali [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] and Ellong A et al. in Cameroon [<xref ref-type="bibr" rid="scirp.119458-ref7">7</xref>]. Among the 68 cases of POAG, the average frequency of ocular hypertonia was 77.94% in our study. This same finding is reported by the majority of studies on blacks [<xref ref-type="bibr" rid="scirp.119458-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.119458-ref15">15</xref>]. It is important to remember that we did not perform pachymetry to determine the central thickness of the cornea in our patients which could be a bias in the assessment of intraocular pressure. Examination of the optic papilla had found a bilateral papillary excavation often asymmetrical with a vertical c/d ratio ≥ 0.8 in 32 right eyes (47.1%) and in 37 left eyes (54.41%). We did not take a picture of the papillae or analyze the papillary optical fibers, which is one of the limitations of the study. Sidib&#233; M et al. [<xref ref-type="bibr" rid="scirp.119458-ref6">6</xref>] and Dabou&#233; A. [<xref ref-type="bibr" rid="scirp.119458-ref14">14</xref>] found a total papillary excavation in 63.89% and 45.5% of the eyes respectively. This confirms the late nature of the diagnosis of glaucoma. In our series, most patients were seen in the advanced stage of the disease in one or both eyes as confirmed by the results of the visual field. This is due to the lack of systematic consultations and early detection strategies in our country.</p></sec><sec id="s5"><title>5. Conclusion</title><p>Our study, although limited by its strict hospital recruitment, showed us that POAG in our environment is relatively frequent, early onset, and rapidly evolving. Screening for this disease is essential because its progression is extremely serious toward irreversible blindness. The implementation of a rapid and reliable screening strategy by the National Eye Health Program to detect glaucoma in the early stages will promote better management of this disease. This work is only a preliminary study. It deserves to be prosecuted on the basis of a population survey.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Lama, P.L., Sylla, A., Camara, S., Sagno, C., Diallo, O.R. and Souar&#233;, I.S. (2022) Incidence of Primary Open-Angle Glaucoma at the Flamboyants Communal Medical Center of Conakry, Guinea. Open Journal of Ophthalmology, 12, 233-241. https://doi.org/10.4236/ojoph.2022.123022</p></sec></body><back><ref-list><title>References</title><ref id="scirp.119458-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Hulsman, C.A., Westendorp, I.C., Ramrattan, R.S., et al. (2001) Is Open-Angle Glaucoma Associated with Early Menopause? The Rotterdam Study. American Journal of Epidemiology, 154, 138-144. https://doi.org/10.1093/aje/154.2.138</mixed-citation></ref><ref id="scirp.119458-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Rudnicka, A.R., Mt-Isa, S., Owen, C.G., et al. (2006) Variations in Primary Open-Angle Glaucoma Prevalence by Age, Gender, and Race: A Bayesian Meta-Analysis. Investigative Ophthalmology &amp; Visual Science, 47, 4254-4261. https://doi.org/10.1167/iovs.06-0299</mixed-citation></ref><ref id="scirp.119458-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Kane, R., Napo, A., Kaba, M., Russo, Y., Toe Vital, R., Bogoreh, A.R., Bamani, S., Landore, A., Traore, M.S., Traore, J. and Lang, B. (2017) Etude du glaucome primitif à angle ouvert à l’Institut d’Ophtalmologie Tropicale Africaine, Mali. Mali Medical, 32, 10-16.</mixed-citation></ref><ref id="scirp.119458-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Lee, A.J., Rochtchina, E., Wang, J.J., et al. (2004) Openangle Glaucoma and Systemic Thyroid Disease in an Older Population: The Blue Mountains Eye Study. Eye (London), 18, 600-608. https://doi.org/10.1038/sj.eye.6700731</mixed-citation></ref><ref id="scirp.119458-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Doshi, V., Ying-Lai, M., Azen, S.P. and Varma, R. (2008) Sociodemographic, Family History, and Lifestyle Risk Factors for Open-Angle Glaucoma and Ocular Hypertension. The Los Angeles Latino Eye Study. Ophthalmology, 115, 639-647. https://doi.org/10.1016/j.ophtha.2007.05.032</mixed-citation></ref><ref id="scirp.119458-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Daboue, A., Meda, N.D. and Ahnoux-Zabsonre, A. (2002) Glaucoma primitif à angle ouvert dans un h&amp;#244;pital du Burkina Faso. Journal Fran&amp;#231;ais d’Ophtalmologie, 25, 39-41.</mixed-citation></ref><ref id="scirp.119458-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Hollows, F.C. and Graham, P.A. (1996) Intraocular Pressure, Glaucoma and Glaucoma Suspects in a Defined Population. British Journal of Ophthalmology, 50, 570-786. https://doi.org/10.1136/bjo.50.10.570</mixed-citation></ref><ref id="scirp.119458-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Quigley, H.A. and Vitale, S. (1997) Models of Open-Angle Glaucoma Prevalence and Incidence in the United States. Investigative Ophthalmology and Visual Science, 38, 83-91.</mixed-citation></ref><ref id="scirp.119458-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Jiang, X., Varma, R., Wu, S., et al. (2012) Baseline Risk Factors That Predict the Development of Open-Angle Glaucoma in a Population: The Los Angeles Latino Eye Study. Ophthalmology, 119, 2245-2253. https://doi.org/10.1016/j.ophtha.2012.05.030</mixed-citation></ref><ref id="scirp.119458-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Leske, M.C., Wu, S.Y., Honkanen, R., et al. (2007) Nine-Year Incidence of Open-Angle Glaucoma in the Barbados Eye Studies. Ophthalmology, 114, 1058-1064. https://doi.org/10.1016/j.ophtha.2006.08.051</mixed-citation></ref><ref id="scirp.119458-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Leske, M.C., Connell, S.Y., Nemesure, B., Li, X., Schachat, A. and Hennis, A. (2001) Incidence of Open-Angle Glaucoma: The Barbados Eye Studies. The Barbados Eye Studies Group. Archives of Ophthalmology, 119, 89-95.</mixed-citation></ref><ref id="scirp.119458-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Moukouri, E. and Moli, M.C. (1991) Le glaucome chronique primitif à angle ouvert en milieu camerounais. Médecine d’Afrique Noire, 38, 577-580.</mixed-citation></ref><ref id="scirp.119458-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Ellong, A., Ebana, C. and Lucienne, A. (2006) Prévalence des glaucomes dans la population noire camerounaise. Santé Médecine, 16, 83-88.</mixed-citation></ref><ref id="scirp.119458-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Sidibe, M., Abdoulaye, A., Fomba, Y., Sidibe, M.K., Bogoreh, R., Dembele, A., et al. (2019) Aspects épidémiologique et clinique du glaucome primitif à angle ouvert en zone rurale. Revue SOAO, 1, 28-33.</mixed-citation></ref><ref id="scirp.119458-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Yehouessi, L., Doutetien, C., Sounouvou, I., Tchabi, S., Avognon, C. and Bassabi, S.K. (2009) Dépistage du glaucome primitif à angle ouvert au centre national hospitalier et universitaire de Cotonou Benin. Journal Fran&amp;#231;ais d’Ophtalmologie, 32, 20-24. https://doi.org/10.1016/j.jfo.2008.11.006</mixed-citation></ref><ref id="scirp.119458-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Tielsch, J.M., Sommer, A., Katz, J., et al. (1991) Racial Variations in the Prevalence of Primary Open Angle Glaucoma. The Baltimore Eye Survey. JAMA, 266, 369-374. https://doi.org/10.1001/jama.1991.03470030069026</mixed-citation></ref><ref id="scirp.119458-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Denis, P. (2002) Glaucome chez le mélanoderme. Journal Fran&amp;#231;ais d’Ophtalmologie, 27, 706-712. https://doi.org/10.1016/S0181-5512(04)96202-X</mixed-citation></ref><ref id="scirp.119458-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Villain, M.A. (2005) Epidémiologie du glaucome. Journal Fran&amp;#231;ais d’Ophtalmologie, 28, 2S9-2S12. https://doi.org/10.1016/S0181-5512(05)81158-1</mixed-citation></ref><ref id="scirp.119458-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Bechetoille, A. (1987) Glaucomes. Japperenard/Dusser, Paris, 488.</mixed-citation></ref></ref-list></back></article>